A primary endpoint analysis of the NRG Oncology Phase III clinical trial NRG-GU003 comparing hypofractionated post-operative prostate bed radiotherapy (HYPORT) to the conventional post-prostatectomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback